Shopping Cart
Remove All
Your shopping cart is currently empty
MY-1B is a nitrogen-containing substituted butenamide stereoprobe, capable of blocking stereoselective enrichment of NSUN2, specifically binding to NSUN2 at C271.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $136 | In Stock | In Stock | |
| 5 mg | $338 | In Stock | In Stock | |
| 10 mg | $538 | In Stock | In Stock | |
| 25 mg | $1,080 | In Stock | In Stock | |
| 50 mg | $1,490 | In Stock | In Stock | |
| 100 mg | $1,980 | In Stock | - | |
| 200 mg | $2,670 | 4-6 weeks | 4-6 weeks |
| Description | MY-1B is a nitrogen-containing substituted butenamide stereoprobe, capable of blocking stereoselective enrichment of NSUN2, specifically binding to NSUN2 at C271. |
| Targets&IC50 | NSUN2 methyltransferase:67 ± 15 M (Kinact/Ki), NSUN2:1.3 μM, NSUN2:2.4 µM (RNA methylation assays) |
| In vitro | Methods: The binding of NSUN2_C271 was observed in the human prostate cancer cell line 22Rv1 treated with 5 or 20 μM MY-1B (3 hours). Results: Almost complete binding of NSUN2_C271 (>90%) was observed in the human prostate cancer cell line 22Rv1. [1] The Kinact/Ki value of MY-1B (2.5-20 µM) against recombinant NSUN2 methyltransferase activity at different pre-incubation times and concentrations was 67±15 M. [1] |
| Synonyms | MY1B |
| Molecular Weight | 436.3 |
| Formula | C22H18BrN3O2 |
| Cas No. | 2929308-79-0 |
| Smiles | C(NC=1C2=C(C=CC1)C=CC=N2)(=O)[C@H]3[C@H](CN3C(C=C)=O)C4=CC=C(Br)C=C4 |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80.00 mg/mL (183.36 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.56 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.